Dimensional Fund Advisors LP Raises Stock Holdings in Addus HomeCare Corporation $ADUS

Dimensional Fund Advisors LP grew its holdings in Addus HomeCare Corporation (NASDAQ:ADUS) by 11.8% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 744,127 shares of the company’s stock after buying an additional 78,415 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Addus HomeCare were worth $69,689,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in ADUS. Capital Research Global Investors lifted its position in shares of Addus HomeCare by 22.3% during the 4th quarter. Capital Research Global Investors now owns 1,469,752 shares of the company’s stock valued at $157,837,000 after buying an additional 268,192 shares in the last quarter. Vanguard Group Inc. grew its stake in Addus HomeCare by 0.8% in the 4th quarter. Vanguard Group Inc. now owns 1,308,605 shares of the company’s stock valued at $140,531,000 after acquiring an additional 10,501 shares during the period. Wasatch Advisors LP increased its holdings in Addus HomeCare by 0.8% in the 3rd quarter. Wasatch Advisors LP now owns 936,243 shares of the company’s stock worth $110,467,000 after acquiring an additional 7,089 shares in the last quarter. State Street Corp increased its holdings in Addus HomeCare by 0.9% in the 4th quarter. State Street Corp now owns 702,229 shares of the company’s stock worth $75,412,000 after acquiring an additional 6,561 shares in the last quarter. Finally, Geode Capital Management LLC raised its position in Addus HomeCare by 0.9% during the fourth quarter. Geode Capital Management LLC now owns 466,006 shares of the company’s stock worth $50,053,000 after acquiring an additional 4,061 shares during the period. 95.35% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

ADUS has been the topic of several recent analyst reports. Citizens Jmp reaffirmed a “market outperform” rating and set a $142.00 price objective on shares of Addus HomeCare in a report on Monday, May 18th. Weiss Ratings raised shares of Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, July 9th. Citigroup restated a “market outperform” rating on shares of Addus HomeCare in a research report on Friday, July 24th. Finally, Barclays raised their price target on shares of Addus HomeCare from $92.00 to $96.00 and gave the company an “underweight” rating in a research note on Wednesday, July 8th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $131.50.

Insiders Place Their Bets

In related news, insider Heather Brianne Dixon sold 288 shares of the business’s stock in a transaction dated Monday, June 22nd. The shares were sold at an average price of $93.77, for a total transaction of $27,005.76. Following the transaction, the insider directly owned 44,371 shares in the company, valued at approximately $4,160,668.67. The trade was a 0.64% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 788 shares of company stock worth $73,506 in the last quarter. Insiders own 4.10% of the company’s stock.

Addus HomeCare Stock Down 1.0%

NASDAQ ADUS opened at $115.48 on Friday. The business has a fifty day moving average price of $101.68 and a 200 day moving average price of $101.47. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.83 and a current ratio of 1.83. The company has a market cap of $2.16 billion, a P/E ratio of 21.35, a P/E/G ratio of 1.60 and a beta of 0.88. Addus HomeCare Corporation has a one year low of $87.95 and a one year high of $124.43.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, May 4th. The company reported $1.62 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.52 by $0.10. Addus HomeCare had a net margin of 6.89% and a return on equity of 9.80%. The company had revenue of $363.50 million for the quarter, compared to analysts’ expectations of $366.41 million. During the same quarter in the previous year, the company posted $1.42 EPS. The firm’s quarterly revenue was up 7.7% on a year-over-year basis. Research analysts anticipate that Addus HomeCare Corporation will post 6.24 EPS for the current fiscal year.

Addus HomeCare Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.